RPCAR01

· Roswell Park Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RPCAR01, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma [Phase 1]

See pricing